Back to Trades
Buy4
Rallybio Corp
RLYB
Total Value
$2.2M
Net $2.2M bought
Purchases
$2.2M
3 transactions
Company Information
- Company Name
- Rallybio Corp
- Ticker Symbol
- RLYB
- CIK
- 0001739410
Insider Information
- Role
- 10% Owner
- Location
- AUSTIN, TX
10% Owner
Filing Details
- Filing Date
- May 6, 2026
- Transaction Date
- May 4, 2026
- Accession Number
- 0001104659-26-056540
- Form Type
- 4
- Net Trading Amount
- $2.2M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | 3,900 | $13.90 | Purchase | $54.2K |
| May 4, 2026 | Common Stock | 116,904 | $13.97 | Purchase | $1.6M |
| May 5, 2026 | Common Stock | 35,101 | $14.00 | Purchase | $491.3K |
Footnotes
- (F1)The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.8611 to $14.0000, inclusive. Each Reporting Person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- (F2)The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.8600 to $14.0000, inclusive. Each Reporting Person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- (F3)The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.9100 to $14.0000, inclusive. Each Reporting Person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- (F4)The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC and separately managed accounts of ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.
- (F5)For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.